ICU Medical Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $2.2B-9.3% YoYTTM through 30 Jun 2026
Net Income $46.3MTTM through 30 Jun 2026
Free Cash Flow $152.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 38.9% |
| EBITDA Margin | 12.7% |
| Operating Margin | 2.6% |
| Net Margin | 5.7% |
Returns
1.4%ROE
0.8%ROA
1.0%ROIC
Balance Sheet Health
Debt / Equity0.61x
Current Ratio2.34x
Net Debt$992.2M
Cash & Equivalents$298.3M
Quality Metrics
Altman Z-Score2.41
FCF Margin7.1%
Rule of 408.5
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $2.2B
Diluted EPS$1.19TTMFY2025: $0.03
Dividend
No dividend
Capital Allocation
R&D Spend$86.3M
Capex Intensity3.9%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.